ClinicalTrialsFinder

Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker) Clinical Trials in Busan

1 recruitingBusan, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Aggressive NK-cell LeukemiaLGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell Lymphoma+10 more
Dren Bio200 enrolled37 locationsNCT05475925